From today’s research to tomorrow’s therapies

1/3

At the heart of the drug discovery ecosystem

Founded in 2008 by Université de Montréal’s Institute for Research in Immunology and Cancer (IRIC), IRICoR is a key player in Quebec’s life sciences ecosystem. Its mission is to accelerate the discovery, development and commercialization of innovative therapies in oncology, immunotherapy and rare diseases.

IRICoR plays an essential role in establishing strategic partnerships with the biopharmaceutical industry or creating spin-off companies, thus facilitating the transformation of academic research projects into new therapies for the benefit of patients. Thanks to its crucial financial support, IRICoR enables researchers to bridge the gap between academic research and the business world.

 

Portfolio

A project today…a treatment for tomorrow

IRICoR works with partners to fund and transform bold ideas into concrete advances, bringing new therapies to cancer patients.